Obesity‐induced inflammation: a metabolic dialogue in the language of inflammation
Anthony W. Ferrante · Journal of Internal Medicine · 2007
Obesity induces an inflammation state that is implicated in many clinically important complications, including insulin resistance, diabetes, atherosclerosis and non-alcoholic fatty liver disease. Although the cause and the molecular participants in this process remain incompletely defined, adipose tissue has a central role. Obesity-induced production of pro-inflammatory molecules, typified by TNF-alpha was recognized more than a dozen years ago, and since then more than two dozen other pro-inflammatory molecules induced by obesity have been identified. More recently a critical role for immune cells, specifically mononuclear phagocytes, in generating the obesity-induced inflammation has been identified. Defining the molecular and cellular components of obesity-induced inflammation offers the potential of identifying therapeutic targets that can ameliorate the complications associated with obesity.
Cited by 611 works. doi:10.1111/j.1365-2796.2007.01852.x
Authors
References
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
- A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
- Obesity is associated with macrophage accumulation in adipose tissue
- Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
- Alternative activation of macrophages
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
- A central role for JNK in obesity and insulin resistance
- Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
- Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB